MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Excessive daytime sleepiness(EDS)"

  • 2018 International Congress

    Safinamide and Rasagiline effect on motor fluctuation, sleep quality and daytime sleepiness in Parkinson’s Disease: A validated questionnaires study

    C. Liguori, A. Stefani, N. Mercuri, M. Pierantozzi (Rome, Italy)

    Objective: This is an observational study aimed at evaluating the effect of Safinamide and Rasagiline on motor fluctuations, subjective sleep and daytime sleepiness in Parkinson’s…
  • 2018 International Congress

    Clinical heterogeneity of excessive daytime sleepiness in Parkinson’s disease

    O. Levin, O. Iakovleva, M. Poluektov (Moscow, Russian Federation)

    Objective: To examine reasons and associated clinical features of excessive daytime sleepiness (EDS) in patients with Parkinson’s disease (PD). Background: Patients with EDS can divided…
  • 2018 International Congress

    Progression of sleep disorders spectrum in Parkinson’s Disease: A 5 year clinical longitudinal study

    Objective: To investigate longitudinal changes in the prevalence of different sleep disorders in the PPMI cohort of patients with Parkinson’s Disease (PD). Background: Sleep disturbances…
  • 2017 International Congress

    Istradefylline improves not only motor symptoms but also sleep disturbance, daytime sleepiness, and QOL of Parkinson’s disease patients.

    K. Ohta, Y. Kujuro, T. Osada (Tokyo, Japan)

    Objective:  This study analyzed the clinical effectiveness of istradefylline in terms of sleep disturbance in Parkinson’s disease (PD) patients. Background: A selective adenosine A2A receptor…
  • 2017 International Congress

    The role of phosphodiesterase 4 in sleep disturbances in Parkinson’s disease

    H. Wilson, G. Pagano, F. Niccolini, N. Muhlert, C. Coello, M. Mehta, G. Searle, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)

    Objective: We aimed to assess the association between phosphodiesterase 4 (PDE4) expression and sleep disturbances in vivo using combined multimodal magnetic resonance imaging (MRI) and…
  • 2017 International Congress

    Relationship between sleep profiles and clinical features in Parkinson’s disease

    Y.-Y. Lin, R.-S. Chen, C.-S. Lu, Y.-Z. Huang, Y.-H. Weng, T.-H. Yeh, W.-Y. Lin, J. Hung (Taoyuan, Taiwan)

    Objective: To document the prevalence of sleep disturbance and excessive daytime sleepiness (EDS) in Taiwanese Parkinson’s disease (PD) patients and to identify the risk factors…
  • 2017 International Congress

    Excessive daytime sleepiness in Parkinson’s disease: risk factors and clinical associations

    O. Babkina, O. Levin, M. Poluektov (Moscow, Russian Federation)

    Objective: To examine the frequency and risk factors of excessive daytime sleepiness (EDS) in patients with PD and to determine relationships between EDS and another…
  • 2017 International Congress

    Somnolence as untoward stimulation effect in subthalamic deep brain stimulation (STN DBS) for Parkinson’s disease (PD)

    F. Danisi, C. Miller (Poughkeepsie, NY, USA)

    Objective: Excessive daytime sleepiness is a relatively common feature in PD. However, it has not been reported as a side effect of STN DBS. We…
  • 2016 International Congress

    J-FIRST: First-in-Japan observational study of Parkinson’s disease treatments and nonmotor symptoms

    T. Maeda, Y. Shimo, S.W. Chiu, T. Yamaguchi, K. Kashihara, Y. Tsuboi, M. Nomoto, N. Hattori, H. Watanabe, H. Saiki (Akita, Japan)

    Objective: To clarify the clinical manifestations of nonmotor symptoms (NMSs) and identify factors affecting NMSs and quality of life (QOL) in Japanese patients with Parkinson's…
  • 2016 International Congress

    Longitudinal assessment of sleep in an incident Parkinson’s disease cohort

    S.T. O'Dowd, G.W. Duncan, T.K. Khoo, A.J. Yarnall, R.A. Lawson, D.J. Burn, K.N. Anderson (Newcastle upon Tyne, United Kingdom)

    Objective: To evaluate subjective and objective measures of sleep disturbance in an incident PD cohort over longitudinal follow-up. Background: Sleep disturbance is widely recognised as…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Unusual prolonged survival in multiple system atrophy: A case report
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley